- 2016344108
- 早期相臨床試験での癌免疫療法開発に関するガイダンス2015(2015 Guidance on cancer immunotherapy development in early-phase clinical studies)(英語)(解説)
- Author:Arato Teruyo(Division of Regulatory Science, Hokkaido University Graduate School of Medicine), Daimon Takashi, Heike Yuji, Ishii Ken, Itho Kyogo, Kageyama Shinichi, Kawakami Yutaka, Nakayama Eiichi, Ozawa Keiya, Sato Noriyuki, Shiku Hiroshi, Takeuchi Masahiro, Tani Kenzaburo, Tamada Koji, Ueda Ryuzo, Yamaguchi Yoshiyuki, Yamanaka Takeharu, Yamaue Hiroki, Yasukawa Masaki, Iguchi Toyotaka, Kitano Shigehisa, Miyahara Yoshihiro, Nagata Yasuhiro, Noguchi Masanori, Terashima Takeshi, Arato Teruyo, Asano Takeo, Asonuma Motohiro, Ikeda Hiroaki, Kakimi Kazuhiro, Takesako Kazutoh, Tanaka Masanori, Amakasu Kohei, Yamada Akira, Harada Naozumi, Aoshi Taiki, Kobiyama Kouji, Muraoka Daisuke, Terashima Takeshi, Yamazaki Naoya, Kuchiba Aya, Tanaka Shiro, Michimae Hirofumi, Yamada Tomomi, Hanada Kenichi, Okada Hideho, Takebe Naoko, Hirano Naoto, Amakasu Kohei, Okumura Satoshi, Sato Daisaku, Shibatsuji Masayoshi, Yamaguchi Teruhide, Guidance Development Review Committee, Working Group for Clinical Studies of Cancer Immunotherapy, Working Group for Effector Cell Therapy, Working Group for CMC/Non-clinical Studies, Working Group for Cancer Vaccines and Adjuvants, Working Group for Anti-immune Checkpoint Therapy and Comprehensive Cancer Immunotherapy, Biostatistics Subcommittee
- Source:Cancer Science(1347-9032)106巻12号 Page1761-1771(2015.12)
|